1. Home
  2. HCKT vs CATX Comparison

HCKT vs CATX Comparison

Compare HCKT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hackett Group Inc (The).

HCKT

Hackett Group Inc (The).

N/A

Current Price

$12.52

Market Cap

330.4M

ML Signal

N/A

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCKT
CATX
Founded
1991
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.4M
113.9M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
HCKT
CATX
Price
$12.52
$0.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
16
Target Price
★ $17.33
$9.43
AVG Volume (30 Days)
227.6K
★ 4.4M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 3.87%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.49
N/A
Revenue
★ $285,862,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.57
$91.56
P/E Ratio
$25.38
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.16
$0.73
52 Week High
$20.68
$6.16

Technical Indicators

Market Signals
Indicator
HCKT
CATX
Relative Strength Index (RSI) 48.54 24.60
Support Level $12.39 N/A
Resistance Level $14.23 $2.40
Average True Range (ATR) 0.53 0.11
MACD -0.16 0.04
Stochastic Oscillator 14.38 5.72

Price Performance

Historical Comparison
HCKT
CATX

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: